Restoration of T cell responsiveness by thymosin: development of antituberculous resistance in BCG infected animals

N. E. Morrison, F. M. Collins

Research output: Contribution to journalArticle

Abstract

T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.

Original languageEnglish (US)
Pages (from-to)554-563
Number of pages10
JournalInfection and Immunity
Volume13
Issue number2
StatePublished - 1976

Fingerprint

Thymosin
Mycobacterium bovis
T-Lymphocytes
Lung
Spleen
Weight Loss
Bone Marrow
DNA
Growth
Population

ASJC Scopus subject areas

  • Immunology

Cite this

Restoration of T cell responsiveness by thymosin : development of antituberculous resistance in BCG infected animals. / Morrison, N. E.; Collins, F. M.

In: Infection and Immunity, Vol. 13, No. 2, 1976, p. 554-563.

Research output: Contribution to journalArticle

@article{561216f352db45069a9413c6d6b71616,
title = "Restoration of T cell responsiveness by thymosin: development of antituberculous resistance in BCG infected animals",
abstract = "T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.",
author = "Morrison, {N. E.} and Collins, {F. M.}",
year = "1976",
language = "English (US)",
volume = "13",
pages = "554--563",
journal = "Infection and Immunity",
issn = "0019-9567",
publisher = "American Society for Microbiology",
number = "2",

}

TY - JOUR

T1 - Restoration of T cell responsiveness by thymosin

T2 - development of antituberculous resistance in BCG infected animals

AU - Morrison, N. E.

AU - Collins, F. M.

PY - 1976

Y1 - 1976

N2 - T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.

AB - T cell depleted (adult thymectomized, lethally irradiated, bone marrow reconstituted [THXB]), sham thymectomized (XB) and normal control mice were injected daily with 3 mg of calf thymosin for 16 days. On day 8 of the treatment, the mice, together with untreated controls, were infected intravenously with 4 X 106 viable Mycobacterium bovis (BCG Montreal). Growth of the BCG in the lungs and spleens was compared quantitatively for up to 100 days. Thymosin treatment reversed the progressive weight loss seen in BCG infected THXB mice and prevented their death due to the ongoing mycobacteriosis that developed in the T cell depleted animal. There was a late developing anti mycobacterial response in the thymosin treated THXB mice, which resulted in a progressive decline in viability for the lung and spleen populations over the 40 to 80 day period, when the corresponding counts for the untreated THXB mice remained relatively constant. The histopathology of the lung and the increased antibacterial activity seen in the thymosin treated THXB mice correlated with decreased [3H]deoxyribonucleic acid levels seen in the lungs and spleen compared with that present in the T cell depleted controls.

UR - http://www.scopus.com/inward/record.url?scp=0017265087&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0017265087&partnerID=8YFLogxK

M3 - Article

C2 - 770334

AN - SCOPUS:0017265087

VL - 13

SP - 554

EP - 563

JO - Infection and Immunity

JF - Infection and Immunity

SN - 0019-9567

IS - 2

ER -